Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NAA50 pseudogene 1 (NAA50P1) refers to a pseudogene, not the functional protein-coding gene NAA50. NAA50 itself encodes an N-alpha-acetyltransferase and NatE complex catalytic subunit, showing broad substrate specificity for N-terminal acetylation of proteins, and is involved in cell cycle, chromatid cohesion, and various cancers[3][5]. However, the pseudogene NAA50P1 does not produce a functional protein and lacks biological activity, molecular classification, or disease relevance associated with drug targets. Information returned here is only about pseudogene status; data for therapeutic target-related entries are not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on N-Alpha-Acetyltransferase 50, NatE Catalytic Subunit (NAA50).